Get research updatesBipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.
This study evaluated the safety and effectiveness of topiramate for people with bipolarity.
This study has finished and is no longer accepting participants.
Location not clearly listedA Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adult Patients With Schizophrenia or Bipolar Disorder and Recent Weight Gain While Taking Antipsychotic Medications (GRATITUDE)
This study has finished and is no longer accepting participants.
Multiple locations, including BentonvilleA Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Birmingham
Accelerated Intermittent Theta Burst Stimulation in Unipolar Versus Bipolar Depression
Current recruitment status is unconfirmed.
In Al MansurahA Single-arm Study to Evaluate Adherence to Treatment With, and Safety and Tolerability of, the Medical Information Device #1 (MIND1) System in Subjects With Schizophrenia or Bipolar I Disorder Who Are Currently Treated With Oral Aripiprazole
This study was withdrawn before enrollment.
Multiple locations, including Cerritos
This study has finished and is no longer accepting participants.
In NiceThe Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Patients With Treatment Resistant Depression and in Patients With Remitted Bipolar Disorder - a Proof of Concept Study
This study has finished and is no longer accepting participants.
In CopenhagenResearchers are comparing Ramelteon SL and placebo to find out how the approaches affect depression symptoms in adults with bipolarity type I.
This study ended early.
Multiple locations, including BirminghamA 6-Month, Open-Label, Flexible-Dosage (150 to 200 mg/Day) Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
This study ended early.
Multiple locations, including BirminghamA Randomized, Double-blind, Double-dummy, Controlled Trial of Lithium Versus Paroxetine in Subjects With Major Depression Who Have a Family History of Bipolar Disorder or Completed Suicide - a Pilot Study
This study ended early.
In HalifaxAn Investigation Examining the Evidence for Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder
This study was withdrawn before enrollment.
In BethesdaNeuroimaging Study of Risk Factors for Adolescent Bipolar Disorder
This study has finished and is no longer accepting participants.
In CincinnatiWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.